158 related articles for article (PubMed ID: 38280070)
1. Establishment and characterization of a novel hypopharyngeal squamous cell carcinoma cell line CZH1 with genetic abnormalities.
Ma J; Zhu X; Heng Y; Ding X; Tao L; Lu L
Hum Cell; 2024 Mar; 37(2):546-559. PubMed ID: 38280070
[TBL] [Abstract][Full Text] [Related]
2. TMEM184B promotes proliferation, migration and invasion, and inhibits apoptosis in hypopharyngeal squamous cell carcinoma.
Lin Y; Liu D; Li X; Ma Y; Pan X
J Cell Mol Med; 2022 Nov; 26(21):5551-5561. PubMed ID: 36254814
[TBL] [Abstract][Full Text] [Related]
3. Single-cell RNA sequencing reveals pro-invasive cancer-associated fibroblasts in hypopharyngeal squamous cell carcinoma.
Cai Z; Chen L; Chen S; Fang R; Chen X; Lei W
Cell Commun Signal; 2023 Oct; 21(1):292. PubMed ID: 37853464
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinoma.
Omura G; Ando M; Ebihara Y; Saito Y; Kobayashi K; Fukuoka O; Akashi K; Yoshida M; Asakage T; Yamasoba T
BMC Cancer; 2017 Dec; 17(1):898. PubMed ID: 29282038
[TBL] [Abstract][Full Text] [Related]
5. Effects of HPV-16 infection on hypopharyngeal squamous cell carcinoma and FaDu cells.
Lu W; Feng L; Li P; Wang Y; Du Y; Chen X; Wu S; Zhao G; Lou W
Oncol Rep; 2016 Jan; 35(1):99-106. PubMed ID: 26497405
[TBL] [Abstract][Full Text] [Related]
6. YTHDF1-enhanced iron metabolism depends on TFRC m
Ye J; Wang Z; Chen X; Jiang X; Dong Z; Hu S; Li W; Liu Y; Liao B; Han W; Shen J; Xiao M
Theranostics; 2020; 10(26):12072-12089. PubMed ID: 33204330
[No Abstract] [Full Text] [Related]
7. HSP90AA1 promotes lymphatic metastasis of hypopharyngeal squamous cell carcinoma by regulating epithelial-mesenchymal transition.
Tang F; Li Y; Pan M; Wang Z; Lu T; Liu C; Zhou X; Hu G
Oncol Res; 2023; 31(5):787-803. PubMed ID: 37547757
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic down-regulation of SOX2 is an independent poor prognostic factor for hypopharyngeal cancers.
Avincsal MO; Jimbo N; Fujikura K; Shinomiya H; Otsuki N; Morimoto K; Furukawa T; Morita N; Maehara R; Itoh T; Nibu KI; Zen Y
Histopathology; 2018 Apr; 72(5):826-837. PubMed ID: 29143365
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of JARID1B promotes differentiation via SHIP1/AKT signaling in human hypopharyngeal squamous cell carcinoma.
Zhang J; An X; Han Y; Ma R; Yang K; Zhang L; Chi J; Li W; Llobet-Navas D; Xu Y; Jiang Y
Cell Death Dis; 2016 Sep; 7(9):e2358. PubMed ID: 27584795
[TBL] [Abstract][Full Text] [Related]
10. DACH1 regulates macrophage activation and tumour progression in hypopharyngeal squamous cell carcinoma.
Li W; Xu L; Cao J; Ge J; Liu X; Liu P; Teng Y; Wang S; Sun Y; Liu M; Tian L
Immunology; 2023 Oct; 170(2):253-269. PubMed ID: 37243970
[TBL] [Abstract][Full Text] [Related]
11. Cetyltrimethylammonium Bromide Attenuates the Mesenchymal Characteristics of Hypopharyngeal Squamous Cell Carcinoma Through Inhibiting the EGFR/PI3K/AKT Signaling Pathway.
Wu TK; Ou YC; Chen YP; Huang FM; Pan YR; Lee CJ
Anticancer Res; 2021 Aug; 41(8):3789-3799. PubMed ID: 34281838
[TBL] [Abstract][Full Text] [Related]
12. Aberrantly expressed genes and miRNAs in human hypopharyngeal squamous cell carcinoma based on RNA‑sequencing analysis.
Li H; Wang F; Fei Y; Lei Y; Lu F; Guo P; Li W; Xun X
Oncol Rep; 2018 Aug; 40(2):647-658. PubMed ID: 29916534
[TBL] [Abstract][Full Text] [Related]
13. FoxM1 overexpression promotes cell proliferation and migration and inhibits apoptosis in hypopharyngeal squamous cell carcinoma resulting in poor clinical prognosis.
Chen Y; Liu Y; Ni H; Ding C; Zhang X; Zhang Z
Int J Oncol; 2017 Oct; 51(4):1045-1054. PubMed ID: 28848994
[TBL] [Abstract][Full Text] [Related]
14. STK33 potentiates the malignancy of hypopharyngeal squamous carcinoma: Possible relation to calcium.
Chen C; Huang L; Zhang G; Li Y; Li L; Bai X; Liu W; Wang H; Li J
Cancer Biol Ther; 2016 Sep; 17(9):976-84. PubMed ID: 27414193
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of hypopharyngeal and laryngeal squamous cell carcinoma sheds light on differences in survival.
Liu J; Zhu W; Li Z; Cai G; Wang J; Tang Q; Maroun CA; Zhu G
Sci Rep; 2020 Nov; 10(1):19459. PubMed ID: 33173143
[TBL] [Abstract][Full Text] [Related]
16. Tumour inflammation signature and expression of S100A12 and HLA class I improve survival in HPV-negative hypopharyngeal cancer.
Mints M; Landin D; Näsman A; Mirzaie L; Ursu RG; Zupancic M; Marklund L; Dalianis T; Munck-Wikland E; Ramqvist T
Sci Rep; 2021 Jan; 11(1):1782. PubMed ID: 33469045
[TBL] [Abstract][Full Text] [Related]
17. A case of peritoneal metastasis during treatment for hypopharyngeal squamous cell carcinoma.
Wakasaki T; Omori H; Sueyoshi S; Rikimaru F; Toh S; Taguchi K; Higaki Y; Morita M; Masuda M
World J Surg Oncol; 2016 Oct; 14(1):265. PubMed ID: 27756320
[TBL] [Abstract][Full Text] [Related]
18. Expression of REG III and prognosis in head and neck cancer.
Masui T; Ota I; Itaya-Hironaka A; Takeda M; Kasai T; Yamauchi A; Sakuramoto-Tsuchida S; Mikami S; Yane K; Takasawa S; Hosoi H
Oncol Rep; 2013 Aug; 30(2):573-8. PubMed ID: 23743605
[TBL] [Abstract][Full Text] [Related]
19. RECQL1 and WRN proteins are potential therapeutic targets in head and neck squamous cell carcinoma.
Arai A; Chano T; Futami K; Furuichi Y; Ikebuchi K; Inui T; Tameno H; Ochi Y; Shimada T; Hisa Y; Okabe H
Cancer Res; 2011 Jul; 71(13):4598-607. PubMed ID: 21571861
[TBL] [Abstract][Full Text] [Related]
20. Treatment patterns and survival outcomes of advanced hypopharyngeal squamous cell carcinoma.
Tsai YT; Chen WC; Chien CY; Hsu CM; Lee YC; Tsai MS; Lin MH; Lai CH; Chang KP
World J Surg Oncol; 2020 May; 18(1):82. PubMed ID: 32357934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
